Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial Post author:Sam Post published:February 5, 2018 Post category:BioPharma The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace You Might Also Like Watch Out: Gilead is Not Done Shopping January 9, 2018 5 Startups to Watch Out For August 22, 2017 What You Need to Know About Shepherd Therapeutics January 16, 2018
